Thrombocytopenia in the sepsis syndrome: Role of hemophagocytosis and macrophage colony-stimulating factor

American Journal of Medicine

Volumn 103, Issue 2, 1997, Pages 114-120

  François, Bruno ^a   Trimoreau, F ^a   Vignon, P ^a   Fixe, P ^a   Praloran, V ^a   Gastinne, H ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; INCIDENCE; MALE; PHAGOCYTOSIS; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELLS; BONE MARROW; FEMALE; HUMANS; INCIDENCE; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; ODDS RATIO; PHAGOCYTOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

EID: 0030743537     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00136-8     Document Type: Article

References (30)

1. Cohen P, Gardner FH. Thrombocytopenia as a laboratory sign and complication of gram-negative bacteremic infection. Arch Intern Med. 1966;117:113-124.
2. Corrigan JJ, Ray WL, May N. Changes in the blood coagulation system associated with septicemia. NEJM. 1968;279:851-856.
3. Risdall RJ, MC Kenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979;44:993-1102.
4. Risdall RJ, Brunning RD, Hernandez JI, Grodon DH. Bacteria-associated hemophagocytic syndrome. Cancer. 1984;54:2968-2972.
5. Albert A, Azgui Z, Buisine J, et al. Macrophage activation syndromes. Nouv Rev Fr Hematol. 1992;34:435-441.
6. Wong KF, Chan JKC. Reactive hemophagocytic syndrome. A clinicopathologic study of 40 patients in an oriental population. Am J Med. 1992;93:177-180.
7. Akashi K, Hayashi S, Gondo H, et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol. 1994;87:243-250.
8. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet. 1991;338:732-736.
9. Bone RC, Fisher CJ, Clemmer TP. Sepsis syndrome a valid clinical entity. Crit Care Med. 1989;17:389-393.
10. Bone RC, Balk RA, Cerra FB, and the ACCP/SCCM consensus conference committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
12. Fagon JY, Chastre J, Novara A, et al. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intens Care Unit. 1993;19:137-144.
13. Praloran V, Martin-Taouvenin V, Berrada L, et al. Intralymphnode injection of human monocyte macrophage colony stimulating factor (CSF-1) as a method of obtaining high titer anti-CSF-1 antibodies. Europ Cytokine Network. 1990;1:177-183.
14. Mire-Sluis AR, Gaines Das R, Thorpe R, et al. Immunological standardization: The international standard for macrophage colony stimulating factor (M-CSF). Evaluation in an international collaborative study. J Immunol Methods. 1995;179:141-152.
15. Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit. Chest. 1993;104:1243-1247.
16. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA. 1995;274:968-974.
17. Poskitt TR, Poskitt PKF. Thrombocytopenia of sepsis. The role of circulating IgG-containing immune complexes. Arch Intern Med. 1985;145:891-894.
18. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medecine. 1988;67:369-388.
19. Henter J, Elinder G, Söder O, et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991;78:2918-2922.
20. Esumi N, Ikusihima SS, Todo S, Imashuku S. Hyperferritinemia in malignant histocytosis and virus-associated hemophagocytic syndrome. NEJM. 1987;316:316-347.
21. Scott RB, Robbsmith AAT. Histiocytic medullary reticulosis. Lancet. 1939;2:194-198.
22. Lortholary A, Raffi F, Aubertin P, et al. HIV-associated haemophagocytic syndrome. Lancet 1990;336:1128.
23. Campo E, Condon E, Miro MJ, et al. Tuberculosis-associated hemophagocytic syndrome. A systemic process. Cancer. 1986;58:2640-2645.
24. Sullivan JL, Woda BA, Herrod HG, et al. Epstein-Barr virus-associated hemophagocytic syndrome: Virological and immunopathological studies. Blood. 1985;65:1097-1104.
25. Waydhas C, Nast-Kolb D, Jochum M, et al. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg. 1992;127:460-467.
26. Imashuku S, Hibi S. Cytokines in haemophagocytic syndrome. Br J Haematol. 1991;77:438-439.
27. Ulich TR, Delcatillo J, Watson LR, et al. In vivo hematologic effects of recombinant macrophage colony-stimulating factor. Blood. 1990;75:846-850.
28. Khwaja A, Johnson B, Addison IE, et al. In vivo effects of macrophage colony-stimulating factor on human monocyte function. Br J Haematol. 1991;77:25-31.
29. Praloran V, Gascan H, Papin S, et al. Inducible production of macrophage colony stimulating factor (CSF1) by malignant and normal human T-cells. Leukemia. 1990;4:411-414.
30. Warren MK, Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol. 1986;137:2281-2285.